Brainsway(BWAY) - 2022 Q1 - Quarterly Report

EXHIBIT 99.1 BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights Revenue Growth of 34% in 2021, with Record Quarterly and Annual Revenues Continued Progress in Expanding FDA Labeling for Deep TMS™ and Increasing Payor Coverage Conference call to be held today, March 9, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, March 09, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive ...